Factors affecting the curative effect of allogeneic stem cell transplantation in patients with high-risk chronic lymphocytic leukaemia

被引：0
|
作者：
Iori, A. P.
Laurenti, L.
Piciocchi, A.
Severino, A.
Chiusolo, P.
Mauro, F. R.
Torelli, G. F.
Della Starza, I.
Majolino, I.
Locasciulli, A.
Meloni, G.
Sica, S.
Leone, G.
Foa, R.
机构：
来源：
BONE MARROW TRANSPLANTATION | 2010年 / 45卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S243 / S244
页数：2
相关论文
共 50 条
  • [11] Stem cell transplantation for chronic lymphocytic leukaemia
    Paneesha, S
    Milligan, DW
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 128 (02) : 145 - 152
  • [12] Venetoclax therapy in chronic lymphocytic leukaemia patients relapsed after allogeneic haematopoietic stem cell transplantation
    Perutelli, Francesca
    Boccellato, Elia
    Montalbano, Maria Chiara
    Catania, Gioacchino
    Deodato, Marina
    Frustaci, Anna Maria
    Innocenti, Idanna
    Moia, Riccardo
    Quaglia, Francesca Maria
    Quaresmini, Giulia
    Rivela, Paolo
    Gaidano, Gianluca
    Krampera, Mauro
    Laurenti, Luca
    Rambaldi, Alessandro
    Bruno, Benedetto
    Vitale, Candida
    Coscia, Marta
    BRITISH JOURNAL OF HAEMATOLOGY, 2025, 206 (03) : 924 - 929
  • [13] Allogeneic stem cell transplantation for patients with high-risk myelodysplastic syndrome
    Hsu, C
    Lin, MT
    Tang, JL
    Tien, HF
    Wang, CH
    Chen, YC
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 1999, 98 (03) : 157 - 164
  • [14] GvHD prophylaxis with sirolimus in combination with mycophenolate mofetil in allogeneic stem cell transplantation for high-risk leukaemia patients
    Schleuning, M.
    Judith, D.
    Bertelsmann, A.
    Jedlickova, Z.
    Heshmat, M.
    Baurmann, H.
    Schwerdtfeger, R.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S227 - S227
  • [15] Thalidomide therapy for refractory chronic lymphocytic leukaemia after allogeneic stem cell transplantation
    Pretnar, J
    Zupan, IP
    BONE MARROW TRANSPLANTATION, 2006, 37 : S341 - S342
  • [16] Allogeneic stem cell transplantation for chronic lymphocytic leukaemia: a single-centre experience
    Valkova, V.
    Vitek, A.
    Pohlreich, D.
    Markova, M.
    Schwarz, J.
    Cetkovsky, P.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S307 - S308
  • [17] Evaluation of allogeneic haematopoietic stem cell transplantation and pre- and post-transplant therapy in high-risk patients with chronic myeloid leukaemia
    Oyekunle, A.
    Klyuchnikov, E.
    Kroeger, N.
    Zabelina, T.
    Ayuk, F.
    Wolschke, C.
    Bernhardt, F.
    Mueller, I.
    Zander, A.
    Bacher, U.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S363 - S363
  • [18] Fludarabine and high-dose cytosine arabinoside followed by allogeneic haematopoietic stem cell transplantation in patients with high-risk leukaemia
    Auberger, J.
    Clausen, J.
    Erdel, M.
    Gunsilius, E.
    Petzer, A.
    Gastl, G.
    Nachbaur, D.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S312 - S313
  • [19] Post-transplant immune reconstitution after allogeneic stem cell transplantation in paediatric patients with high-risk leukaemia
    Rigatou, E.
    Gumy-Pause, F.
    Mattiello, V.
    Chalandon, Y.
    Ansari, M.
    Ozsahin, H.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S149 - S150
  • [20] Update on post transplant immune reconstitution after allogeneic stem cell transplantation in paediatric high-risk leukaemia patients
    Rigatou, E.
    Pause, F. Gummy
    Mattiello, V.
    Chalandon, Y.
    Ansari, M.
    Ozsahin, H.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S366 - S367
12345